News
Updates from the healthcare landscape and the impact of Algocyte.
Oxford Immune Algorithmics (OIA) Successfully Completes QMS ISO 13485
Oxford Immune Algorithmics (OIA), the creators of Algocyte, is delighted to announce it has successfully received ISO 13485 certification status from NQA.
Oxford Immune Algorithmics is Part of the UAE and Hub71’s World Tour to #LondonTechWeek and #VivaTech in Paris.
This past week represented a significant one for Oxford Immune Algorithmics (OIA).
Oxford Immune Algorithmics’ (OIA) AI-driven Solution Algocyte Featured on UK’s Open Access Media Portal on SARS-CoV-2 and Long Covid
We recently published an article on the U.K.’s Open Access Media portal entitled, ‘Could Immune Monitoring Be the Route to a Long-Covid Test?‘
Oxford Immune Algorithmics, Representing the UK as One of its Most Innovative Companies, Successfully Concludes Multiple Events in Dubai
Oxford Immune Algorithmics announced they are exhibiting at MWC/4YFN in Barcelona, February 28th – March 3rd.
Oxford Immune Algorithmics, Creators of the AI-driven Solution Algocyte, Features Star Trek’s Commander Riker in new Video.
Oxford Immune Algorithmics (OIA), the award-winning A.I. company that specialises in rapid at-home testing for immune health monitoring, and the creators of Algocyte, know something about legacy.
Oxford Immune Algorithmics (OIA) Appointed a Corporate Member of the Canadian College of Health Leaders.
The Canadian College of Health Leaders (CCLH) has announced the appointment of Oxford Immune Algorithmics (OIA) as a new corporate member of CCHL.
Oxford Immune Algorithmics’ (OIA) Algocyte, Voted one of Top 5 UK Precision Medicine Solutions
Oxford Immune Algorithmics (OIA)
Oxford Immune Algorithmics Has a Spot at GITEX, the World’s Largest Technology Event in Dubai
Oxford Immune Algorithmics recently participated in the 41st GITEX Global event hosted at the Dubai World Trade Centre in Dubai, UAE.
Oxford Immune Algorithmics Announces Appointment of Mr. Tony Cambridge to its Scientific Advisory Board
Oxford Immune Algorithmics, growing by leaps and bounds, recently announced the appointment of Mr. Tony Cambridge to its Scientific Advisory Board.
Oxford Immune Algorithmics Announces Appointment of Dr. Corey Cutler, Medical Oncology Innovator to its Scientific Advisory Board
Oxford Immune Algorithmics is proud to announce the appointment of internationally recognised innovator, Dr. Corey Cutler, to its Scientific Advisory Board.
Oxford Immune Algorithmics’ (OIA) Founder Invited to ‘Founder’s Forum’ Event during London’s Tech Week.
An exceptional experience was planned for a select group of tech Startup founders last week in London. The Founder’s Forum & Mubadala Capital Ventures hosted a special Founder’s Forum event celebrating London’s Tech Week.
Oxford Immune Algorithmics (OIA) Collaboration with the World’s First AI University MBZUAI
The mission of MBZUAI is to be the hub of fundamental AI research, training and transformation, and the global epicentre of research in the field. It is the world’s first university committed to AI, which makes the MBZUAI a perfect partner.
Oxford Immune Algorithmics (OIA) Secures A Coveted Spot In The UK Pavilion At The Dubai World Expo 2020
The UK’s Departament of International Trade recently announced the selection of Oxford Immune Algorithmics (OIA) as one of the health-tech companies that will participate in the UK’s Health Technology Showcase at Expo 2020.
Oxford Immune Algorithmics Expands And Accelerates By Graduating From German-based Spinlab Accelerator Program
Oxford Immune Algorithmics (OIA), creator of the Algocyte health-tech venture, has officially graduated from the Class No. 11 German-based SpinLab accelerator.
Oxford Immune Algorithmics Announces Appointment Of Pioneering Academic Dr. Jason Berman To Its Scientific Advisory Board
Oxford Immune Algorithmics’ trajectory as a Medtech and Biotech company continues to accelerate. The award-winning company recently announced the appointment of pioneering…
Oxford Immune Algorithmics Graduates From Global Creative Destruction Lab Program
We are proud to announce that Oxford Immune Algorithmics (OIA), creator of Algocyte, is part of the Creative Destruction Lab-Toronto Health Diagnostics Stream’s 2020/21 graduating cohort…
OIA, Key Partner In UK’s EPSRC Research Network, Awarded Grant To Explore The Future Of Blood Testing
Oxford Immune Algorithmics’ (OIA) continues to be acknowledged both internationally and in the U.K. The recent announcement of the award of…
Oxford Immune Algorithmics Wins International AI Competition To Predict Etihad’s Cash Flow Validating OIA’s AI Predictive Algorithms
Oxford Immune Algorithmics (OIA) has been announced the winner of Etihad’s AI international competition. Etihad Group Finance, owner of award-winning Abu Dhabi-based Etihad Airlines…
Oxford Immune Algorithmics (OIA) Partners With Myglobalhome To Revolutionise Healthcare In The Home
OIA’s flagship AI Medical Assistant, Algocyte, will be integrated into MyGlobalHome’s digital health ecosystem, allowing users to complete personal blood tests remotely at will…
Oxford Immune Algorithmics Secures £5.1m To Advance Remote Health Monitoring And Precision Medicine
Drawing on more than a decade of research in computational biology and systems medicine conducted at institutions such as the the University of Oxford…